P719: RANDOMIZED PHASE 1-2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: IN... by Garcia-Manero, Guillermo, Bachishvili, Kimo, A. Griffiths, Elizabeth, M. Zeidan, Amer, Traer, Elie, Saini, Lalit, Amin, Harshad, Mohan, Sanjay, Lübbert, Michael, Maness-Harris, Lori, M Foran, James, Selleslag, Dominik, Xicoy Cirici, Blanca, Aaron Pollyea, Daniel, Sallman, David, Al-Kali, Aref, Berdeja, Jesus, Kathrin Al-Ali, Haifa, Y Zhu, Nancy, Font Lopez, Patricia, Sanz Santillana, Guillermo, Santini, Valeria, A. Yimer, Habte, D Cripe, Larry, Priego, Victor, Odenike, Olatoyosi, Heyrman, Bert, Valcarcel, David, Vachhani, Pankit, Sano, Yuri, Mirakhur, Beloo, Oganesian, Aram, Keer, Harold, Yacoub, Abdulraheem

Get full text

Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL by Al-Kadhimi, Zaid, Pirruccello, Samuel, Gul, Zartash, Maness-Harris, Lori, Bhatt, Vijaya Raj, Gundabolu, Krishna, Yuan, Jane, Lunning, Matthew, Bociek, Gregory, D’Angelo, Christopher, Kallam, Avyakta, Armitage, James, Abdullah, Khansa, Hunter, Angela, Mccaslin, Sarah, Lyden, Elizabeth, Smith, Lynnette, Callahan, Michael, Cole, Kathryn, Hinrichs, Steven, Talmadge, James, Vose, Julie

Get full text

Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study by Garcia-Manero, Guillermo, Abaza, Yasmin, Takahashi, Koichi, Medeiros, Bruno C., Arellano, Martha, Khaled, Samer K., Patnaik, Mrinal, Odenike, Olatoyosi, Sayar, Hamid, Tummala, Mohan, Patel, Prapti, Maness-Harris, Lori, Stuart, Robert, Traer, Elie, Karamlou, Kasra, Yacoub, Abdulraheem, Ghalie, Richard, Giorgino, Ruben, Atallah, Ehab

Get full text

MDS-641 Randomized Phase 1-2 Study to Assess Safety and Efficacy of Low-Dose (LD) Oral Decitabine/Cedazuridine (ASTX727) in Lower-Risk Myelodysplastic Syndromes (LR-MDS) Patients:... by Garcia-Manero, Guillermo, Bachiashvili, Kimo, Griffiths, Elizabeth A., Zeidan, Amer M., Traer, Elie, Saini, Lalit, Amin, Harshad, Mohan, Sanjay, Lubbert, Michael, Maness-Harris, Lori, Foran, James, Selleslag, Dominik, Xicoy, Blanca, Pollyea, Daniel A., Sallman, David A., Al-Kali, Aref, Berdeja, Jesus G., Al-Ali, Haifa, Zhu, Nancy Y., Lopez, Patricia Font, Santillana, Guillermo Sanz, Santini, Valeria, Yimer, Habte, Cripe, Larry D., Priego, Victor, Odenike, Olatoyosi, Heyrman, Bert, Ferreiras, David Valcarcel, Vachhni, Pankit J, Chan, Winny, Sano, Yuri, Mirakhur, Beloo, Oganesian, Aram, Keer, Harold, Yacoub, Abdulraheem

Get full text

POSTER: MDS-641 Randomized Phase 1-2 Study to Assess Safety and Efficacy of Low-Dose (LD) Oral Decitabine/Cedazuridine (ASTX727) in Lower-Risk Myelodysplastic Syndromes (LR-MDS) Pa... by Garcia-Manero, Guillermo, Bachiashvili, Kimo, Griffiths, Elizabeth A., Zeidan, Amer M., Traer, Elie, Saini, Lalit, Amin, Harshad, Mohan, Sanjay, Lubbert, Michael, Maness-Harris, Lori, Foran, James, Selleslag, Dominik, Xicoy, Blanca, Pollyea, Daniel A., Sallman, David A., Al-Kali, Aref, Berdeja, Jesus G., Al-Ali, Haifa, Zhu, Nancy Y., Lopez, Patricia Font, Santillana, Guillermo Sanz, Santini, Valeria, Yimer, Habte, Cripe, Larry D., Priego, Victor, Odenike, Olatoyosi, Heyrman, Bert, Ferreiras, David Valcarcel, Vachhni, Pankit J, Chan, Winny, Sano, Yuri, Mirakhur, Beloo, Oganesian, Aram, Keer, Harold, Yacoub, Abdulraheem

Get full text

Two Step Anti-Thymocyte Globulin (ATG) Is Associated with No Severe Acute Graft Versus Host Disease and Favorable Immune Reconstitution Post Allogeneic Hematopoietic Stem Cell Tran... by Al-Kadhimi, Zaid, Maness-Harris, Lori, Gundabolu, Krishna, Bhatt, Vijaya Raj, Bociek, R. Gregory, Lunning, Matthew, Pirrucello, Samuel, Lyden, Elizabeth, Pravoverov, Kristina, Talmadge, James, Vose, Julie M.

Get full text

Revisiting Use of Growth Factors in Myelodysplastic Syndromes by Newman, Kam, Maness-Harris, Lori, El-Hemaidi, Ihab, Akhtari, Mojtaba

Get full text

P719: RANDOMIZED PHASE 1‐2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW‐DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS) PATIENTS: IN... by Garcia‐Manero, Guillermo, Bachishvili, Kimo, A. Griffiths, Elizabeth, M. Zeidan, Amer, Traer, Elie, Saini, Lalit, Amin, Harshad, Mohan, Sanjay, Lübbert, Michael, Maness‐Harris, Lori, M Foran, James, Selleslag, Dominik, Xicoy Cirici, Blanca, Aaron Pollyea, Daniel, Sallman, David, Al‐Kali, Aref, Berdeja, Jesus, Kathrin Al‐Ali, Haifa, Y Zhu, Nancy, Font Lopez, Patricia, Sanz Santillana, Guillermo, Santini, Valeria, A. Yimer, Habte, D Cripe, Larry, Priego, Victor, Odenike, Olatoyosi, Heyrman, Bert, Valcarcel, David, Vachhani, Pankit, Sano, Yuri, Mirakhur, Beloo, Oganesian, Aram, Keer, Harold, Yacoub, Abdulraheem

Get full text

Revisiting Use of Growth Factors in Myelodysplastic Syndromes by Newman, Kam, Maness-Harris, Lori, El-Hemaidi, Ihab, Akhtari, Mojtaba

Get full text

Urothelial cell intracytoplasmic inclusions after treatment of promyelocytic leukemia with arsenic trioxide by Wedel, Whitney R, Muirhead, David E, Arnold, Lora L, Dodmane, Puttappa R, Lele, Subodh M, Maness-Harris, Lori, Hoyt, Rose, Cohen, Samuel M

Get full text